Mohammed Ayaz Ali։ HIT – When an Anticoagulant Causes Thrombosis
Mohammed Ayaz Ali, Clinical Pharmacist at Helping Hand Foundation (NGO), shared a post on LinkedIn:
“Heparin-Induced Thrombocytopenia (HIT): When an Anticoagulant Causes Thrombosis
A falling platelet count after starting heparin might sound like a bleeding problem.
But in HIT, the bigger danger is often the opposite: Thrombosis.
A fascinating example of how a medication can trigger a paradoxical clinical emergency.
1.What is HIT?
HIT is an immune-mediated adverse reaction to heparin.
Antibodies form against PF4–heparin complexes, activating platelets and generating a strongly prothrombotic state.
2.The classic clue
Think about HIT when there is:
- Significant platelet fall
- Typically 5-10 days after heparin exposure
- New thrombosis
- No obvious alternative explanation
A platelet count falling after heparin should not automatically be dismissed as bleeding risk.
3.Why is it dangerous?
Activated platelets can produce:
- Deep-vein thrombosis
- Pulmonary embolism
- Arterial thrombosis
- Limb ischemia
- Stroke
The paradox is striking:
Platelets fall – thrombosis rises.
4.Where clinicians can miss it
The mistake can be assuming:
‘Low platelets means stop anticoagulation.’
In suspected HIT, the clinical approach is fundamentally different and requires urgent evaluation.
The 4Ts score can help estimate the pretest probability before laboratory confirmation.
5. A Message to healthcare professionals
Whenever platelet counts fall after heparin exposure, don’t look at the platelet number alone.
Ask:
- When did the fall begin?
- How large was the fall?
- Was there new thrombosis?
- Could heparin be responsible?
Sometimes, the most important clue is not the number.
It is the timeline.”

Stay updated with Hemostasis Today.
-
Nov 20, 2026, 04:46Alessandra Bosch: Swiss Haemophilia Network Wins Research Grant
-
Nov 20, 2026, 04:41Courtney Lawrence: HLA Antibodies and Platelet Transfusion Refractoriness in Hispanic Patients
-
Nov 20, 2026, 04:24Kamand Haeri: Platelet Function Testing by Flow Cytometry in Patients with BDUC at SOHC 2026
-
Nov 20, 2026, 00:33Overcoming Barriers to Diagnosis and Treatment for Women With Bleeding Disorders – EHC
-
Nov 20, 2026, 00:27Vera Stroikova: Key Takeaways on Electrophysiology and Stroke Prevention From the New Horizons 2026
-
Nov 20, 2026, 00:20Devi G. Nair Enrolls First US Patient in Smartphone Camera Atrial Fibrillation Detection Study
-
Nov 20, 2026, 00:14Saskia de Pee: Fortified Rice Cuts Anemia Risk by 57%
-
Nov 20, 2026, 00:02Andres Zuleta: Evaluating the RISE UP Trial Results on Mitapivat for Sickle Cell Disease
-
Nov 19, 2026, 23:57Greta Hametner: Preventing Maternal Cardiac Complications Through Preconception Iron and Thyroid Screening